The Fibromyalgia Family Study: A Genome‐Wide Linkage Scan Study
Objective Familial aggregation of fibromyalgia has been increasingly recognized. The goal of this study was to conduct a genome‐wide linkage scan to identify susceptibility loci for fibromyalgia. Methods We genotyped members of 116 families from the Fibromyalgia Family Study and performed a model‐fr...
Saved in:
Published in: | Arthritis & rheumatology (Hoboken, N.J.) Vol. 65; no. 4; pp. 1122 - 1128 |
---|---|
Main Authors: | , , , , , , , |
Format: | Journal Article |
Language: | English |
Published: |
Hoboken
Wiley Subscription Services, Inc., A Wiley Company
01-04-2013
Wiley Subscription Services, Inc |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Objective
Familial aggregation of fibromyalgia has been increasingly recognized. The goal of this study was to conduct a genome‐wide linkage scan to identify susceptibility loci for fibromyalgia.
Methods
We genotyped members of 116 families from the Fibromyalgia Family Study and performed a model‐free genome‐wide linkage analysis of fibromyalgia with 341 microsatellite markers, using the Haseman‐Elston regression approach.
Results
The estimated sibling recurrence risk ratio (λs) for fibromyalgia was 13.6 (95% confidence interval 10.0–18.5), based on a reported population prevalence of 2%. Genome‐wide suggestive evidence of linkage was observed at markers D17S2196 (empirical P [Pe] = 0.00030) and D17S1294 (Pe = 0.00035) on chromosome 17p11.2–q11.2.
Conclusion
The estimated sibling recurrence risk ratio (λs) observed in this study suggests a strong genetic component of fibromyalgia. This is the first report of genome‐wide suggestive linkage of fibromyalgia to the chromosome 17p11.2–q11.2 region. Further investigation of these multicase families from the Fibromyalgia Family Study is warranted to identify potential causal risk variants for fibromyalgia. |
---|---|
Bibliography: | Dr. Olson is deceased. Drs. Arnold and Fan contributed equally to this work. Dr. Kushner has provided expert testimony as a medical expert for administrative law judges of the Office of Disability Adjudication and Review of the Social Security Administration. ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 0004-3591 2326-5191 1529-0131 2326-5205 |
DOI: | 10.1002/art.37842 |